Yayın: Why does post-transplant osteonecrosis develop?
| dc.contributor.buuauthor | Ersoy, Alparslan | |
| dc.contributor.buuauthor | Ersoy, Canan Özyardımcı | |
| dc.contributor.department | Tıp Fakültesi | |
| dc.contributor.department | Tıp Fakültesi | |
| dc.contributor.department | Nefroloji Ana Bilim Dalı | |
| dc.contributor.department | Endokrinoloji ve Metabolizma Ana Bilim Dalı | |
| dc.contributor.orcid | 0000-0002-0710-0923 | |
| dc.contributor.researcherid | AAH-5054-2021 | |
| dc.contributor.researcherid | AAH-8861-2021 | |
| dc.contributor.scopusid | 35612977100 | |
| dc.contributor.scopusid | 6701485882 | |
| dc.date.accessioned | 2024-04-18T05:38:27Z | |
| dc.date.available | 2024-04-18T05:38:27Z | |
| dc.date.issued | 2007-08 | |
| dc.identifier.citation | Ersoy, A. ve Ersoy, C. Ö. (2007). ''Why does post-transplant osteonecrosis develop?''. Nephrology Dialysis Transplantation, 22(8), 2412-2412. | |
| dc.identifier.doi | 10.1093/ndt/gfm198 | |
| dc.identifier.endpage | 2412 | |
| dc.identifier.issn | 0931-0509 | |
| dc.identifier.issue | 8 | |
| dc.identifier.pubmed | 17442738 | |
| dc.identifier.scopus | 2-s2.0-34547851692 | |
| dc.identifier.startpage | 2412 | |
| dc.identifier.uri | https://doi.org/10.1093/ndt/gfm198 | |
| dc.identifier.uri | https://watermark.silverchair.com/gfm198.pdf?token=AQECAHi208BE49Ooan9kkhW_Ercy7Dm3ZL_9Cf3qfKAc485ysgAAAs4wggLKBgkqhkiG9w0BBwagggK7MIICtwIBADCCArAGCSqGSIb3DQEHATAeBglghkgBZQMEAS4wEQQMSDazRyhGEp1S5oacAgEQgIICgZk01BIShkmzMi5M7-FO-1PUTSE6pojS29VeT-CkbLk8Hhj1xhRm6bSY6Lfhf3x6MqeGVQ-_CmX2gLzCX05dw_4TCk5A8klN2k0BaNEDoQYPu31s_Ds-kEDJLK0iZ6_Im8rjmFelN4wSQgawNq40DFNPSketC9yuyKEaA4XhgGzU1IbMlvlpFQGhR59OMh4qWl_NmOV3dZnIjNvLYtoFcmOjquqauyEUAJJOjTcJFwMkwDmBY3Ox4gxrfX79x_r_brT-Yomynte-qtHqkLVKj4QNOmvJODAZaG_alYM6uQFW4E7GNtuHj6kl2oIZuLfPIS8_TnbZHkeI8sD1p9v85wqTBma9pXf8uV70gHU2tqzIsy5oueLAQO1TjxkUkyzi7uQnrBcj8iPwuiEc4VvRTFyScmRe4Z6ERYs1I-Wj4iNa90M8I7BV95F2NMF-YfAtBeSoWrmaYreWs_CXYCc5CYpnrejYhISX0pfewOA2rfqGgB4shRPuVIPPr1pBbOGOFIxeiI9MjK-3dRPj5cPUCp64d4-Q_GKSZGcse2cA0fUrrE5abi0L7CzTKsDbMoNE5vYg_qJRcYMoHy0vzBpEtXYIDuCkhTxlJ70wenE5zohoZ_ydfAuSlfKXFRCKTv1nFjAriNtjU0LmHpGiIBq5g1uoD_565apAdL_SFIstxz96iQfRHbqIr6_akLQKNgS1ZokCoeo-HLrhk0mOj_NG0t7j2mHF390g8DH4RaijMbfhid571s3GGs6IkE_CfxV_pSF_orwveMdjBIxXB6L-4s-0bJj1GFhjPND3EeYSbsfGkVhvURl_zw3EnnUDlsyN-_aZNLATleGPdNvKnrD1Nazw | |
| dc.identifier.uri | https://hdl.handle.net/11452/41162 | |
| dc.identifier.volume | 22 | |
| dc.identifier.wos | 000249243500060 | |
| dc.indexed.wos | SCIE | |
| dc.language.iso | en | |
| dc.publisher | Oxford Univ Press | |
| dc.relation.journal | Nephrology Dialysis Transplantation | |
| dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi | |
| dc.rights | info:eu-repo/semantics/openAccess | |
| dc.subject | Transplantation | |
| dc.subject | Urology & nephrology | |
| dc.subject | Renal-allograft recipients | |
| dc.subject | Association | |
| dc.subject | Femoral-head | |
| dc.subject | Prothrombin | |
| dc.subject | Avascular osteonecrosis | |
| dc.subject | Pathogenesis | |
| dc.subject | Factor-v | |
| dc.subject | Osteoporosis | |
| dc.subject | Gene | |
| dc.subject | Transplantation | |
| dc.subject.emtree | Apoptosis | |
| dc.subject.emtree | Bone density | |
| dc.subject.emtree | Corticosteroid induced osteoporosis | |
| dc.subject.emtree | Disease association | |
| dc.subject.emtree | Drug megadose | |
| dc.subject.emtree | Femur head necrosis | |
| dc.subject.emtree | Gene mutation | |
| dc.subject.emtree | Genetic association | |
| dc.subject.emtree | Genetic predisposition | |
| dc.subject.emtree | Graft recipient | |
| dc.subject.emtree | Heterozygosity | |
| dc.subject.emtree | Human | |
| dc.subject.emtree | Kidney transplantation | |
| dc.subject.emtree | Letter | |
| dc.subject.emtree | Mutational analysis | |
| dc.subject.emtree | Osteoblast | |
| dc.subject.emtree | Osteocyte | |
| dc.subject.emtree | Osteoporosis | |
| dc.subject.emtree | Priority journal | |
| dc.subject.emtree | Side effect | |
| dc.subject.emtree | Thrombophilia | |
| dc.subject.emtree | Thrombosis | |
| dc.subject.emtree | 5,10 methylenetetrahydrofolate reductase (fadh2) | |
| dc.subject.emtree | Adenine | |
| dc.subject.emtree | Bisphosphonic acid derivative | |
| dc.subject.emtree | Blood clotting factor 5 leiden | |
| dc.subject.emtree | Cyclosporin a | |
| dc.subject.emtree | Cytosine | |
| dc.subject.emtree | Glucocorticoid | |
| dc.subject.emtree | Guanine | |
| dc.subject.emtree | Hydroxymethylglutaryl coenzyme a reductase inhibitor | |
| dc.subject.emtree | Plasminogen activator inhibitor 1 | |
| dc.subject.emtree | Prothrombin | |
| dc.subject.emtree | Steroid hormone | |
| dc.subject.emtree | Thymine | |
| dc.subject.mesh | Factor v | |
| dc.subject.mesh | Femur head necrosis | |
| dc.subject.mesh | Humans | |
| dc.subject.mesh | Kidney transplantation | |
| dc.subject.mesh | Mutation | |
| dc.subject.mesh | Polymorphism, genetic | |
| dc.subject.mesh | Postoperative complications | |
| dc.subject.mesh | Prothrombin | |
| dc.subject.mesh | Thrombophilia | |
| dc.subject.mesh | Thrombosis | |
| dc.subject.wos | Transplantation | |
| dc.subject.wos | Urology & nephrology | |
| dc.title | Why does post-transplant osteonecrosis develop? | |
| dc.type | Article | |
| dc.wos.quartile | Q1 (Urology & Nephrology) | |
| dc.wos.quartile | Q2 (Transplantation) | |
| dspace.entity.type | Publication | |
| local.contributor.department | Tıp Fakültesi/Nefroloji Ana Bilim Dalı | |
| local.contributor.department | Tıp Fakültesi/Endokrinoloji ve Metabolizma Ana Bilim Dalı | |
| local.indexed.at | WOS | |
| local.indexed.at | Scopus |
Dosyalar
Lisanslı seri
1 - 1 / 1
